Private Equity VC Fund Investments
Vaccine technology startup Mynvax raises $2-M from Inviga Healthcare Fund
Mynvax , a Bangalore-based biotech startup focused on developing novel recombinant vaccines for human respiratory viral diseases, including seasonal influenza and Covid-19, has raised USD 2 million from Inviga Healthcare Fund.
Company website ↗ (opens in a new tab)
In Jul-21, Mynvax - which was incubated at IISc-Bangalore - had raised USD 4.2 million in a round led by Accel India with participation from Kotak PE, Lets Venture and other angel investors.